Nigel A Buist, MD in Eden, NC - Medicare Obstetrics/gynecology

Nigel A Buist, MD is a medicare enrolled "Obstetrics & Gynecology" physician in Eden, North Carolina. He graduated from medical school in 1978 and has 46 years of diverse experience with area of expertise as Obstetrics/gynecology. He is a member of the group practice Unc Physicians Network and his current practice location is 522 S. Van Buren Rd., Eden, North Carolina. You can reach out to his office (for appointments etc.) via phone at (336) 627-1117.

Nigel A Buist is licensed to practice in North Carolina (license number 35287) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1609808054.

Contact Information

	Nigel A Buist, MD
	522 S. Van Buren Rd., Eden, NC 27288-5201
	(336) 627-1117
	(336) 627-5502

Physician's Profile

Full Name	Nigel A Buist
Gender	Male
Speciality	Obstetrics/gynecology
Experience	46 Years
Location	522 S. Van Buren Rd., Eden, North Carolina
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Nigel A Buist graduated from medical school in 1978

NPI Data:

NPI Number: 1609808054
Provider Enumeration Date: 07/07/2006
Last Update Date: 05/06/2021

Medicare PECOS Information:

PECOS PAC ID: 2769565795
Enrollment ID: I20080213000511

Medical Identifiers

Medical identifiers for Nigel A Buist such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1609808054	NPI	-	NPPES
6259812	Medicaid	VA
8919650	Medicaid	NC

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207V00000X	Obstetrics & Gynecology	35287 (North Carolina)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Unc Physicians Network	5496940546	709

News Archive

Studies find night shift work has little or no effect on woman's breast cancer risk

Despite an assessment in 2007 indicating that night shift work was probably carcinogenic, data from three new studies and from a review of currently available evidence, published in the Journal of the National Cancer Institute, indicate that night shift work has little or no effect on breast cancer incidence.

Universal Detection signs deal with U.S. to become Featured U.S. Exporter of bioterrorism monitoring equipment in France

Universal Detection Technology, a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, announced today that the company has entered an agreement with U.S. Department of Commerce's Commercial Service to become a Featured U.S. Exporter (FUSE) of bioterrorism monitoring equipment in France.

CYP1B1 protein prevents head and neck cancers, say researchers

Head and neck cancers typically begin in squamous cells that line moist surfaces inside the mouth, nose and throat. Squamous cell carcinoma of the head and neck (HNSCC) is the sixth most common type of cancer in the United States, and it is sometimes preceded by the appearance of changes inside the oral cavity called precancerous lesions.

Next-generation sequencing technology effective for detecting BRCA1 and BRCA2 mutations

The recognition of a causal link between mutations in BRCA1 and BRCA2 genes and increased risk of developing breast and ovarian cancer has intensified the demand for genetic testing. Identifying mutations in these large genes by conventional methods can be time consuming and costly.

Neogenix Oncology's registration statement on Form 10 filed with SEC becomes effective

Neogenix Oncology announced today that its registration statement on Form 10 as amended, filed with the Securities and Exchange Commission (SEC) to register its common stock pursuant to Section 12(g) of the Securities Exchange Act of 1934, has become effective. The Form 10 includes a description of the business of the company, management's discussion and analysis of financial condition, financial statements for the past two years and the first quarter of 2010, as well as other legal and financial disclosures such as risk factors.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Nigel A Buist allows following entities to bill medicare on his behalf.

Entity Name	Unc Physicians Network Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1750704367 PECOS PAC ID: 5496940546 Enrollment ID: O20101115000646

News Archive

Studies find night shift work has little or no effect on woman's breast cancer risk

Universal Detection signs deal with U.S. to become Featured U.S. Exporter of bioterrorism monitoring equipment in France

CYP1B1 protein prevents head and neck cancers, say researchers

Next-generation sequencing technology effective for detecting BRCA1 and BRCA2 mutations

Neogenix Oncology's registration statement on Form 10 filed with SEC becomes effective

Entity Name	Unc Rockingham Health Care Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1538664099 PECOS PAC ID: 6800157181 Enrollment ID: O20180605000262

Studies find night shift work has little or no effect on woman's breast cancer risk

Universal Detection signs deal with U.S. to become Featured U.S. Exporter of bioterrorism monitoring equipment in France

CYP1B1 protein prevents head and neck cancers, say researchers

Next-generation sequencing technology effective for detecting BRCA1 and BRCA2 mutations

Neogenix Oncology's registration statement on Form 10 filed with SEC becomes effective

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Nigel A Buist is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Nigel A Buist, MD 2000 Perimeter Park Dr Ste 200, Morrisville, NC 27560-8442 Ph: (984) 215-4110	Nigel A Buist, MD 522 S. Van Buren Rd., Eden, NC 27288-5201 Ph: (336) 627-1117

News Archive

Studies find night shift work has little or no effect on woman's breast cancer risk

Universal Detection signs deal with U.S. to become Featured U.S. Exporter of bioterrorism monitoring equipment in France

CYP1B1 protein prevents head and neck cancers, say researchers

Next-generation sequencing technology effective for detecting BRCA1 and BRCA2 mutations

Neogenix Oncology's registration statement on Form 10 filed with SEC becomes effective

Obstetrics & Gynecology Doctors in Eden, NC

William J. Mcleod, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 522 S. Van Buren Rd., Eden, NC 27288 Phone: 336-627-1117 Fax: 336-627-5502
Dionne P. Galloway, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 522 S. Van Buren Rd., Eden, NC 27288 Phone: 336-627-1117 Fax: 336-627-5502

Nigel A Buist, MD - Medicare Obstetrics/gynecology in Eden, NC

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Studies find night shift work has little or no effect on woman's breast cancer risk

Universal Detection signs deal with U.S. to become Featured U.S. Exporter of bioterrorism monitoring equipment in France

CYP1B1 protein prevents head and neck cancers, say researchers

Next-generation sequencing technology effective for detecting BRCA1 and BRCA2 mutations

Neogenix Oncology's registration statement on Form 10 filed with SEC becomes effective

Medicare Reassignments

Studies find night shift work has little or no effect on woman's breast cancer risk

Universal Detection signs deal with U.S. to become Featured U.S. Exporter of bioterrorism monitoring equipment in France

CYP1B1 protein prevents head and neck cancers, say researchers

Next-generation sequencing technology effective for detecting BRCA1 and BRCA2 mutations

Neogenix Oncology's registration statement on Form 10 filed with SEC becomes effective

Studies find night shift work has little or no effect on woman's breast cancer risk

Universal Detection signs deal with U.S. to become Featured U.S. Exporter of bioterrorism monitoring equipment in France

CYP1B1 protein prevents head and neck cancers, say researchers

Next-generation sequencing technology effective for detecting BRCA1 and BRCA2 mutations

Neogenix Oncology's registration statement on Form 10 filed with SEC becomes effective

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Studies find night shift work has little or no effect on woman's breast cancer risk

Universal Detection signs deal with U.S. to become Featured U.S. Exporter of bioterrorism monitoring equipment in France

CYP1B1 protein prevents head and neck cancers, say researchers

Next-generation sequencing technology effective for detecting BRCA1 and BRCA2 mutations

Neogenix Oncology's registration statement on Form 10 filed with SEC becomes effective

Obstetrics & Gynecology Doctors in Eden, NC